Cointime

Fonds Vives II (University of Louvain, UCL)

investment firm

About

Fonds Vives II (University of Louvain, UCL)

Highlights

Investments
5
Exits
1

Details

Operating Status
Active

Investments

Number of Investments
Number of Lead Investments
5
0
Fonds Vives II (University of Louvain, UCL) has made 5 investments. Their most recent investment was on Dec 15, 2021, when Sunrise raised €6.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 15, 2021 Sunrise
Seed €6.50M Health Care —
May 28, 2020 Virovet
Series B €6M Biotechnology —
Jun 20, 2018 ITeos Therapeutics
Series B $75M Biotechnology —
Apr 27, 2018 A-Mansia Biotech
Series A €13M Biopharma —
May 3, 2012 ITeos Therapeutics
Series A €9M Biotechnology —

Exits

Fonds Vives II (University of Louvain, UCL) has had 1 exits. Fonds Vives II (University of Louvain, UCL) most notable exits include ITeos Therapeutics

Date Company Name Exit Type Industry
Jul 23, 2020 ITeos Therapeutics IPO Biotechnology Detail
Cointime
เนื้อหา
บริษัท